ClinicalTrials.Veeva

Menu

Long Outcome of Endoscopic Submucosal Dissection for Small Gastrointestinal Stromal Tumors (<2cm)

N

Nanfang Hospital, Southern Medical University

Status

Unknown

Conditions

GIST

Treatments

Procedure: ESD

Study type

Interventional

Funder types

Other

Identifiers

NCT03082079
LC2016YM002

Details and patient eligibility

About

Data are currently insufficient to guide the management of very small gastrointestinal stromal tumors(GISTs)(< 2 cm) discovered incidentally on endoscopy,this study is designed to collect the medical records of patients in different treatment group with long-term follow-up data,and attempts to evaluate the usefulness of regular endoscopic ultrasound(EUS)surveillance and the necessity,safety and feasibility of endoscopic submucosal dissection(ESD)for small GISTs,thus provide evidence for the revision of the guideline.

Full description

OBJECTION:to evaluate the usefulness of regular endoscopic ultrasound(EUS) surveillance and the necessity,safety and feasibility of endoscopic submucosal dissection(ESD) for small GISTs(<2cm),thus providing evidences for the revision of the guideline.

OUTLINE:This is a randomized controlled trial. Eligible patients are divided into 2 group with 45 in each.The experimental group undergo ESD for GISTs,while the investigators do no treatment to the control group.Then,the 2 groups will be follow up for 5 years.All data are analysed with the Statistical Product and Service Solutions(SPSS)statistical software.

Enrollment

90 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male or female chinese patients of 18-70 years old.
  2. Patients with very small gastric GISTs (< 2 cm) with no high-risk EUS features.
  3. Patients voluntarily join this study with informed consents.

Exclusion criteria

  1. Patients with the tumors involving the serosa layer or grow outside the lumen obviously that are not eligible for endoscopic treatment.
  2. Patients with distant metastasis on computed tomography(CT)scan.
  3. patients with an extremely poor general condition or a very short life expectancy.
  4. Patients presenting with severe gastrointestinal tract bleeding that require immediate surgery.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

90 participants in 2 patient groups

ESD group
Experimental group
Description:
Patient in this group undergo ESD for GIST, and regular follow-up are carried out for these patients on 72 ±3h,7±2d,14±2d,3 month,6 month,1 year,2 year,3 year,4 year,5 year after the treatment. The investigators record the success rate of operation,en bloc resection,operation time,complication rate,hospitalization days,hospitalization expenses,pathology results and tumor recurrence rate.
Treatment:
Procedure: ESD
Follow-up group
No Intervention group
Description:
Patient in this group are given no intervention,the investigators record the tumor size and EUS features of the first endoscopic examination.Regular follow-up are carried out for these patients on 3 month,6 month,1 year,2 year,3 year,4 year,5 year after this check.Then,tumor size and EUS features of each time are collected accurately.

Trial contacts and locations

0

Loading...

Central trial contact

yue li, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems